The Venture Codex Logo

The Venture Codex

YK Bioventures

398 Primrose Road, Suite 238, Burlingame, CA, 94010, United States

Overview

Venture fund investing in biotech and supporting new technologies.

Founded

2023

Deals · 12mo

8

Links

LinkedIn

Stage focus

Seed
Series A
Series B

Geographic focus

United States

Sector focus

Finance
Financial Services
FinTech
Venture Capital

Investment portfolio

13rounds
NAMEDATESIZE
Tempo Therapeutics
Sep 2026Participated
$15 MDebt
Moonwalk Biosciences
Sep 2026Led
$70 MSeries B
Think Bioscience
Jan 2026Participated
$55 MSeries A
Vivere Oncotherapies
Jan 2026Led
$10 MOther Equity
PsiThera
Dec 2025Participated
$48 MSeries A
Triana Biomedicines
Dec 2025Participated
$120 MSeries B
Protego Biopharma
Dec 2025Participated
$130 MSeries B
Pelage Pharma
Oct 2025Participated
$120 MSeries B
Normunity
Jan 2025Participated
$75 MSeries B
āshibio
Jun 2024Participated
$40 MSeed
Think Bioscience
May 2024Led
$6 MSeed
Pelage Pharma
Feb 2024Participated
$17 MSeries A
Tempo Therapeutics
Sep 2026Participated
$15 MDebt
Moonwalk Biosciences
Sep 2026Led
$70 MSeries B
Think Bioscience
Jan 2026Participated
$55 MSeries A
Vivere Oncotherapies
Jan 2026Led
$10 MOther Equity
PsiThera
Dec 2025Participated
$48 MSeries A
Triana Biomedicines
Dec 2025Participated
$120 MSeries B
Protego Biopharma
Dec 2025Participated
$130 MSeries B
Pelage Pharma
Oct 2025Participated
$120 MSeries B
Normunity
Jan 2025Participated
$75 MSeries B
āshibio
Jun 2024Participated
$40 MSeed
Think Bioscience
May 2024Led
$6 MSeed
Pelage Pharma
Feb 2024Participated
$17 MSeries A
13
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

YK Bioventures: 13 funding rounds are recorded in the selected participation categories.All available history.
YK Bioventures: 13 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed11
Series A04
Series B14
Other Equity10
Debt01

Monthly Deal Activity

YK Bioventures: 13 deals are recorded across 34 months.All available history.
YK Bioventures: 13 deals are recorded across 34 months. All available history
MonthDeals
Jan '241
Feb '241
Mar '240
Apr '240
May '241
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '253
Jan '262
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '262
Oct '260

Sector Breakdown

YK Bioventures: Health & Life Sciences is the largest displayed sector by deal count (13 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

YK Bioventures: Health & Life Sciences is the largest displayed sector by deal count (13 deals). All available history
SectorDeals
Health & Life Sciences13
AI & Machine Learning2
Space & Frontier Tech1

Deal Size Distribution

YK Bioventures: 13 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

YK Bioventures: 13 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M3
$25M-$50M2
$50M-$100M4
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

YK Bioventures: United States has the largest recorded deal count among the displayed regions (13 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

YK Bioventures: United States has the largest recorded deal count among the displayed regions (13 deals). All available history
RegionDeals
United States13
YK Bioventures: 20 co-investors are shown, with ARCH Venture Partners sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

YK Bioventures: 20 co-investors are shown, with ARCH Venture Partners sharing 3 recorded deals. All available history
Co-investorShared deals
ARCH Venture Partners3
Google Ventures3
Regeneron Ventures3
Future Ventures2
Khosla Ventures2
Lightspeed Venture Partners2
Main Street Advisors2
MPM Capital2
Pfizer Ventures2
Samsara BioCapital2
Visionary Ventures2
Agent Capital1
Alpha Wave Global1
Alpha Wave Ventures1
Ascenta Capital1
Atlas Venture1
AV8 Ventures1
Berkeley Frontier Fund1
Bessemer Venture Partners1
Buff Gold Ventures1

Investment Strategy

YK Bioventures: Led accounts for 23% and participating for 77% of round participation.All available history.
YK Bioventures: Led accounts for 23% and participating for 77% of round participation. All available history
CategoryDeals (count)Share (%)
Led323%
Participating1077%
YK Bioventures: Single-lead accounts for 67% and co-led for 33% of lead dynamics.All available history.
YK Bioventures: Single-lead accounts for 67% and co-led for 33% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead267%
Co-led133%

Team

Gary Yeung

Co-Founder and Co-CIO